| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/07/2013 | WO2013018899A1 Dibenzooxepin derivative |
| 02/07/2013 | WO2013018886A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
| 02/07/2013 | WO2013018837A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | WO2013018829A1 Method for treating cancer by combined use of medicinal agents |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018706A1 Composition for regulating urat1 activity |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018675A1 N-hetero-ring-substituted amide derivative |
| 02/07/2013 | WO2013018587A1 Tyrosinase inhibitor produced using dried earthworm powder, and method for producing same |
| 02/07/2013 | WO2013018374A1 Ketone derivative and drug containing same |
| 02/07/2013 | WO2013018371A1 Biaryl ester derivative and drug containing same |
| 02/07/2013 | WO2013018169A1 Antimicrobial activity enhancing agent |
| 02/07/2013 | WO2013017475A1 New use of l-histidine and derivatives thereof |
| 02/07/2013 | WO2012174049A3 Compositions and methods for controlling neuronal excitation |
| 02/07/2013 | US20130035353 Drugs for the treatment of sarcoglycanopathies |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130035287 Transient immortalization |
| 02/07/2013 | US20130034534 Method for treatment of patients with cystic fibrosis |
| 02/07/2013 | CA2844197A1 Treatment of fibrosis using microrna-19b |
| 02/07/2013 | CA2844037A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
| 02/07/2013 | CA2844032A1 Method for treating cancer by combined use of drugs |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843238A1 N-hetero-ring-substituted amide derivative |
| 02/07/2013 | CA2842906A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | CA2842891A1 Tyrosinase inhibitor produced using dried earthworm powder, and method for producing same |
| 02/06/2013 | EP2554546A1 Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2554178A1 Expression modulator for clock gene period |
| 02/06/2013 | EP2554177A1 Expression modulator for clock gene bmal |
| 02/06/2013 | EP2554167A1 New use of l-histidine and derivatives thereof |
| 02/06/2013 | EP2552462A2 Ccn3 peptides and analogs thereof for therapeutic use |
| 02/06/2013 | EP2552461A1 The therapeutic use of tetrathiomolybdate |
| 02/06/2013 | EP2552435A1 Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1) |
| 02/06/2013 | CN1993327B 3-Carbamoyl-2-pyridone derivative |
| 02/06/2013 | CN1378445B Drug releasing biodegradable fiber implant |
| 02/06/2013 | CN102918040A Purinone derivative |
| 02/06/2013 | CN102917726A Interferon analogs |
| 02/06/2013 | CN102917723A Soybean protein hydrolysate-containing antioxidant and use thereof |
| 02/06/2013 | CN102917718A Mesenchymal stem cell inducer, and method for induction of mesenchymal stem cell |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102911190A Ethanol 2-hydroxyl naphthylaldehyde thiosemicarbazone o-phenanthroline polymerized metal complex and application thereof |
| 02/06/2013 | CN102911117A Naphthylamine derivative and purpose thereof |
| 02/06/2013 | CN102908632A Process for producing placebo of traditional Chinese medicine formula granule |
| 02/06/2013 | CN102908630A 6-modified bicyclic nucleic acid analogs |
| 02/06/2013 | CN102908539A Traditional Chinese medicine for treating menopausal night sweats and preparation method of same |
| 02/06/2013 | CN102908352A Application of terazosin or its salt in preparing drug for treating septicemia/stroke |
| 02/06/2013 | CN101583366B Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 02/06/2013 | CN101554382B New purpose of triterpene substance |
| 02/05/2013 | US8367738 Smooth muscle contraction inhibitors |
| 02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
| 02/05/2013 | US8367631 Pharmaceutical composition which improves in vivo gene transfer |
| 02/05/2013 | US8367623 Glycolipid and medicine for autoimmune disease containing the same as active ingredient |
| 02/05/2013 | US8367619 Methods for promoting elastogenesis and elastin fiber formation by increasing tropoelastin expression |
| 02/05/2013 | US8367605 Copolymer-1 improvements in compositions of copolymers |
| 02/05/2013 | US8367118 Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/05/2013 | US8367063 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 02/05/2013 | US8367057 Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 02/05/2013 | CA2665762C Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 02/05/2013 | CA2629977C Extract of dioscorea sp. and the medical uses thereof |
| 02/05/2013 | CA2557766C Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 02/05/2013 | CA2515975C Peptide derivatives having .beta.-secretase inhibitory activity |
| 02/05/2013 | CA2501719C Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 02/05/2013 | CA2492273C 3, 10, and 12a substituted tetracycline compounds |
| 02/05/2013 | CA2464277C Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 02/05/2013 | CA2443275C Improved gene expression |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 02/05/2013 | CA2420867C Methods for enhancing the efficacy of cancer therapy |
| 01/31/2013 | WO2013015388A1 Ndm inhibitor |
| 01/31/2013 | WO2013015288A1 Lipase activity inhibitor |
| 01/31/2013 | WO2013014921A1 Agent for increasing serotonin in brain |
| 01/31/2013 | WO2013014535A1 Methods and compositions for enhancing t cell diversity |
| 01/31/2013 | WO2013014073A1 Phospholipid-detergent conjugates and uses thereof |
| 01/31/2013 | WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
| 01/31/2013 | WO2013013496A1 Drink composition for clearing inner heat and preparation method thereof |
| 01/31/2013 | US20130030034 Modulation of timp1 and timp2 expression |
| 01/31/2013 | US20130030021 Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and 1-Oxoisoindolines and Method of Reducing TNFalpha Levels |
| 01/31/2013 | US20130030000 Pharmaceutical compositions for the treatment of pain and other indications |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130029915 Crosslinked human or animal tissue products and their methods of manufacture and use |
| 01/31/2013 | US20130028997 Compositions, Products, Therapeutic Uses and Procedures for the Production and/or Crystallization of Extracts of Encelia Canescens LAM (Coronilla De Fraile) |
| 01/31/2013 | US20130028910 Hmg1 antibody for treating inflammatory conditions |
| 01/31/2013 | CA2842730A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
| 01/30/2013 | EP2551262A1 Glutamate derivatives or salts thereof |
| 01/30/2013 | EP2549999A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 01/30/2013 | CN102905763A Lipids, lipid compositions, and methods of using them |
| 01/30/2013 | CN102905706A Pharmaceutical composition containing solifenacin |
| 01/30/2013 | CN102905702A Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient |
| 01/30/2013 | CN102901826A New potential human cytokine TMEM98 and uses thereof |
| 01/30/2013 | CN102898380A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898349A Solid containing compound, a composition containing the solid and use of the solid |
| 01/30/2013 | CN102895629A Preparation technology and production method for integrated new formulation of cassia twig and oyster decoction |
| 01/30/2013 | CN102895588A Traditional Chinese medicine for treatment of multisystemic wasting syndrome of piglet |
| 01/30/2013 | CN102895570A Detoxifying and growth-promoting premix made of natural plant for livestock and preparation method thereof |
| 01/30/2013 | CN102895538A Preparation technology and production method for integrated new formulation of white tiger and genseng decoction |
| 01/30/2013 | CN102895496A Preparation technology and production method for integrated new formulation of lily and anemarrhena decoction |
| 01/30/2013 | CN102895343A Chinese medicinal composition for clearing heat, eliminating dampness, releasing toxin, reducing swelling, eliminating stagnation and relieving pain and preparation method for Chinese medicinal composition |
| 01/30/2013 | CN102895339A Chinese medicinal composition with summerheat dispelling and exterior syndrome relieving functions and its preparation method |
| 01/30/2013 | CN102895283A Xi Huang dropping pill molding process |
| 01/30/2013 | CN102895189A Gingerol liposome and preparation method thereof |